Table 3. Validated constructs.
| Name | Abreviation | Number of probes | Number of distinct probes |
|---|---|---|---|
| “Greenish” Fluorescent Protein (EGFP, EYFP, and ECFP) | g_FP | 19 | 19 |
| SV40 large T antigen | SV40 | 18 | 18 |
| Cre recombinase | Cre | 16 | 12 |
| Tetracycline repressor protein | tTA | 14 | 14 |
| Diptheria toxin | DTA | 11 | 11 |
| Human CMV enhancer version b | hCMV_b | 10 | 7 |
| Luciferase and firefly luciferase | Luc | 10 | 10 |
| Chloramphenicol acetyltransferase | chloR | 9 | 9 |
| Bovine growth hormone poly A signal sequence | bpA | 8 | 4 |
| iCre recombinase | iCre | 8 | 8 |
| Reverse improved tetracycline-controlled transactivator | rtTA | 8 | 4 |
| CRISPR associated protein 9 | cas9 | 7 | 7 |
| Blasticidin resistance | BlastR | 6 | 4 |
| Internal Ribosome Entry Site | IRES | 6 | 6 |
| hCMV enhancer version a | hCMV_a | 5 | 4 |
| “Reddish” fluorescent protein (tdTomato, mCherry) | r_FP | 6 | 6 |
| Herpesvirus TK promoter | hTK_pr | 2 | 2 |
| Total | 163 | 145 |
The table lists the name, abbreviation shown in the report and the number of total and distinct probes for 17 constructs validated in the data set reported here. EGFP, enhanced green fluorescent protein; EYFP, enhanced yellow fluorescent protein; ECFP, enhanced cyan fluorescent protein; CMV, cytomegalovirus; hCMV, human cytomegalovirus; SV40, simian virus 40; TK, thymidine kinase.